Programme
09:15-10:00
Registration and welcome coffee
10:00 - 10:05
Welcome speech
Martina Brzková – Health Attaché, Permanent Representation of the Czech Republic to the European Union
10:05 -10:15
Introductory remarks
Jakub Dvořáček – Deputy Minister, Ministry of Health of the Czech Republic
Elisabeth Stampa – Medicines for Europe President and CEO Medichem
10:15-11:20
Session 1: Sustainable and equitable access to medicines in Central and Eastern Europe
Equitable access to medicines and the sustainability of healthcare systems remains a challenge for many European governments. In this context, off-patent medicines play an essential role in promoting pharmaceutical innovation and, through competition contribute massively to the affordability, sustainability, and accessibility of healthcare systems. The greater use of generic and biosimilar medicines in the CEE region could be a catalyst to dramatically improve access to medicines and to improve health outcomes, as found in the recent Medicines for Europe report “Removing access barriers in Central and Eastern Europe: How can we ensure equitable access to medicines for all European patients?”
MODERATOR: Dave Keating - Brussels Correspondent, France 24
PANELLISTS:
Jakub Dvořáček - Deputy Minister, Ministry of Health of the Czech Republic
Vera Pataki - Head of International Market Access, EGIS and Chair of the CEE Network, Medicines for Europe
Zoltán Kaló - Professor of Health Economics
at Center for Health Technology Assessment, Semmelweis
University
Gergely Németh - Project Manager, EURIPID at the National Institute of Health Insurance Fund Management
(NEAK)
Robert Hejzák – Board Chair, National Association of Patient Organizations (NAPO), Czech Republic
11:20-11:40 Coffee break
11:40-12:45
Session 2: Increasing
Manufacturing Resilience for security of supply
and equitable access
Cost-containment and the Industrial consolidation of the
sector run counter to the EU’s commitment to increase manufacturing resilience
and diversity and reduce reliance on third countries. To reverse industrial
consolidation and promote open strategic autonomy in medicines manufacturing,
the Czech Presidency can stimulate progress on a policy environment that
solidifies security of supply for equitable access to medicines.
MODERATOR: Dave Keating – Brussels Correspondent, France 24
PANELLISTS:
Giacomo Mattinò - Head of Unit,
Food, Retail, Health, DG Internal
Market, Industry, Entrepreneurship and SMEs, European
Commission
Marian Piecha - Deputy Minister, Ministry of
Industry and Trade of the Czech Republic
Elisabeth
Stampa - Medicines for Europe
President and CEO
Medichem
Steffen Denzinger - President European Fine Chemicals Group (EFCG) and Director Business Development Actives &
Formulation Merck KGaA
Soňa Porubská - Head of Corporate Affairs Zentiva Global and ČAFF Board member
12:45-13:00
Concluding remarks
Marian Piecha - Deputy Minister, Ministry of Industry and Trade of the Czech Republic
Philippe Drechsle - Vice President EU Portfolio, TEVA and Medicines for Europe Executive Committee member
13:00 Buffet lunch